Continuous glucose monitoring, usually shortened to CGM, is the use of a wearable or implanted sensor to measure glucose trends every few minutes and send those readings to a receiver, phone, watch, or app. Most current CGM systems are minimally invasive rather than fully non-invasive because they use a small filament or implanted sensor that samples glucose in interstitial fluid.
Why It Matters
CGM matters because glucose changes continuously while fingerstick checks only capture isolated moments. A stronger monitoring system can show current level, rate of change, time in range, overnight trends, and alerts for hypo- or hyperglycemia. That makes it easier to see patterns that single spot checks can miss.
Where AI Fits
AI helps CGM by filtering noisy signals, forecasting near-term glucose excursions, prioritizing alerts, and connecting glucose trends to meals, exercise, medication timing, and other behavioral context. This is why CGM often overlaps with digital biomarkers, remote patient monitoring, time series forecasting, and clinical decision support.
CGM is also the practical benchmark for many newer non-invasive systems. When a watch-based or needle-free model claims to estimate glucose, it is often being evaluated against CGM or blood-glucose reference data rather than operating as a validated replacement from day one.
What To Keep In Mind
CGM is powerful, but it is not the same as an instant venous blood measurement. Interstitial readings can lag behind blood glucose, alerts can fail if software delivery breaks, and device performance can vary across conditions such as compression, exercise, or rapidly changing glucose. Strong systems therefore need good alert design, quality monitoring, and clear user guidance.
Related Yenra articles: Non-Invasive Glucose Monitoring Analysis, Health Monitoring Wearables, Telemedicine, and Patient Data Management.
Related concepts: Digital Biomarker, Remote Patient Monitoring, Time Series Forecasting, and Clinical Decision Support.